Fiona Farr BSc - PowerPoint PPT Presentation

1 / 20
About This Presentation
Title:

Fiona Farr BSc

Description:

Case Study: The pharmaceutical industry under siege' What do the KOLs want ... How good are pharmaceutical companies at communicating commitment to advancement ... – PowerPoint PPT presentation

Number of Views:37
Avg rating:3.0/5.0
Slides: 21
Provided by: nigelgr
Category:
Tags: bsc | farr | fiona

less

Transcript and Presenter's Notes

Title: Fiona Farr BSc


1
Lowering a vital drawbridge
  • Fiona Farr BSc Nigel Griffiths BSc PhD

MEDICAL MARKETING RESEARCH International
MEDICAL MARKETING STUDIES, US Inc. THE KOL
EXPERTS Working with KOLs for gt15yrs
2
The objective...
  • What do the worlds top OPINION LEADERS in 5
    markets of critical interest to the Industry have
    to say about a Pharmaceutical Industry Under
    Siege?

3
Agenda
  • Methodology Guaranteeing objectivity and a true
    measure of influence
  • OPEXTM
  • Opinion Leader Insight Study
  • Case Study The pharmaceutical industry under
    siege
  • What do the KOLs want from industry?
  • What can the industry get from partnering with
    KOLs?
  • How good are pharmaceutical companies at
    communicating commitment to advancement of
    healthcare?
  • Who are the peacemakers? Who pours boiling oil?
  • How can agencies optimize the way they work with
    Opinion Leaders?
  • Lowering some drawbridges

4
How are Opinion Leaders traditionally identified?
5
Ask the Marketplace...
We have developed our own methodology (over the
last 15 years) to identify Opinion Leaders based
on peer nomination OPEXTM
We approach these objectively identified KOLs in
our KOL market research studies
6
Who did we speak to in this research?
  • Professors at the top universities
  • Speakers at international congresses
  • Government advisors
  • Consultants on pharmacos scientific advisory
    boards

Boehringer Ingelheim
Novartis
AstraZeneca
Pfizer
JJ
Merck
Lilly
BMS
GSK
these are the KOLs you are working closely
with and are the individuals who INFLUENCE
OPINIONS OF YOU AND YOUR PRODUCTS
7
The KOL tightrope
8
What does a KOL seek from the pharmaceutical
industry?
A place at the cutting edge
Research
Platform/ Prestige
Foreknowledge
Advancement of their thinking
Personal
9
What do KOLs have to offer the pharmaceutical
industry?
RD Advice
Objective synthesis
Global overview
Education (medics)
Strategic input
Marketing Guidance
Product Advocacy
10
How good are pharmaceutical companies at
communicating commitment to advancement of
healthcare?
THE MOST CONCERNING FINDING
  • and were not aware of anything being done to
    address this negative image.

11
Who does it well? Who does it badly?
  • Pure Marketeers
  • The Researchers, The Scientists, The Educators
  • Poor communicators e.g. of the rationale for
    costing
  • Team up with non profit-
  • making organizations
  • Complacency e.g. re off-label indications
  • Focus on patient care
  • Research grants to look at more than their own
    drug
  • The me-too approach to development
    commercially, not scientifically driven
  • The groundbreakers who answer scientifically
    meaningful Qs
  • Those who pursue surrogate markers and not QoL

12
What do KOLs want to give the industry?
13
The dos and don'ts of relationship building
DONT
  • Try to control them telling them exactly how,
    what and when to present
  • Slip into the hired gun trap
  • Overtly sell
  • Slam your competitors
  • Discourage frankness
  • Rely on CROs to be your ambassador

14
The dos and don'ts of relationship building
DO
  • Identify with their mission for the betterment of
    pts
  • Give feedback on their contribution
  • Provide a stimulating and unbiased (or less
    biased) forum for discussion
  • Support investigator-initiated research which
    explores the wider scientific questions
  • Communicate the basis of their selection
  • Involve them in education
  • Have Specialist KOL liaison (with continuity of
    contact)
  • Pay them well!

15
Recent tightening of conflict of interest
regulations
  • NEGATIVE
  • Too stringent
  • A licence for censorship by pharmacos?
  • POSITIVE
  • Transparency expected and needed in this sector

16
How can agencies improve the way they work with
KOLs?
THE MOST WELCOME FINDING!
OVERALL, VERY POSITIVE FEEDBACK
Areas to improve on
  • Knowledge of interviewer
  • Remembering the true meaning of in-depth
  • Not asking about drug costs or demographics
  • Considered use of on-line discussions with
    multiple feedback sessions

Key recommendation
Use us post-launch as well
17
Concluding thoughts.
18
Lowering the drawbridge to CONSUMERS...
19
Lowering the drawbridge to OPINION LEADERS...
Get the balance right!
20
and finally your homework in Naples
I hear and I forget... I see and I
remember... I do and I understand. Confuciu
s
  • Thanks for your attention!
Write a Comment
User Comments (0)
About PowerShow.com